![Kathleen Richton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Richton
Director of Finance/CFO at
ENGENE THERAPEUTICS INC.
Net worth: 11 937 $ as of 29/06/2026
Profile
Ms. Kathleen Richton is a Senior VP, Chief Financial & Accounting Officer at enGene Therapeutics, Inc. Ms. Richton was previously employed as a Vice President & Controller by Sunovion Pharmaceuticals, Inc. She received her undergraduate degree from Bentley University and a graduate degree from Bentley University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/07/2026 | 6,900 ( 0.01% ) | 11 937 $ | 29/06/2026 |
Kathleen Richton active positions
| Companies | Position | Start |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Director of Finance/CFO | 15/07/2026 |
Former positions of Kathleen Richton
| Companies | Position | End |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Comptroller/Controller/Auditor | 30/06/2023 |
Training of Kathleen Richton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Kathleen Richton
